Skip to main content

Gencell Licenses SAS Software

NEW YORK, Feb. 25 (GenomeWeb News) - SAS has licensed its Scientific Discovery Solutions software to Gencell, the company said today.

 

Gencell, a subsidiary of Aventis Pharma, will use the package, including SAS Research Data Management, SAS Microarray Solution, and SAS Enterprise Miner, to analyze and manage gene expression data, to handle data from clinical trials, and to develop electronic filings to health authorities.

 

Last month, Bristol-Myers Squibb said it will test SAS software for gene expression analysis and proteomics.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.